Pfizer – Best Practices in HR+ HER2- Metastatic Breast Cancer Medical Management

Well-being, Health and Biomedical Discovery


Academic Unit: Inquire with Unit

Memorial Deadline: Friday 17th, September 2021

External Deadline: Wednesday 22nd, September 2021


Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.

For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.

Geographic Scope: Latin America, Africa, Middle East and Asia-Pacific*(except China)

Clinical Area: Oncology – Breast Cancer

Link to full RFP: Best Practices in HR+ HER2- Metastatic Breast Cancer Medical Management

Application Due Date: September 22, 2021

Specific Area of Interest: Healthcare professionals need to understand the latest scientific data in order to make evidence-based treatment decisions and provide optimal care for patients with ER+ HER2- metastatic breast cancer. Areas of interest include but not limited to:
• Understanding and applying clinical guidelines in practice.
• Interpreting real-world evidence/real-world data and its applicability to treatment decision making.

The intent of this RFP is to encourage medical education proposals under the following format: Online, virtual, technology-enabled activities that have a wide reach to a large number of healthcare professionals in the regions of interest. All medical education organizations are encouraged to apply. Activities should primarily be in English although translated resources to other languages would also be of interest. Practical tools to support clinical practice and patient education are also in-scope of this RFP. Proposals can be either:
• Regional, multi-country programs.
• Country, locally led programs.

Funding Sources

Pfizer Inc

This opportunity was posted by: RGCS

Last modified: August 9, 2021